LOESTRIN 21 1/2021 Day (Teva Women’s Health, Inc.)
Welcome to the PulseAid listing for the LOESTRIN 21 1/20 drug offered from Teva Women’s Health, Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Women’s Health, Inc. |
| NON-PROPRIETARY NAME: | Norethindrone Acetate/Ethinyl Estradiol |
| SUBSTANCE NAME: | NORETHINDRONE ACETATE; ETHINYL ESTRADIOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-02-26 |
| END MARKETING DATE: | 0000-00-00 |
LOESTRIN 21 1/20 21 Day HUMAN PRESCRIPTION DRUG Details:
| Item Description | LOESTRIN 21 1/20 21 Day from Teva Women’s Health, Inc. |
| LABELER NAME: | Teva Women’s Health, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1; 20(mg/1; ug/1) |
| START MARKETING DATE: | 2015-02-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51285-131_d37e7e14-9f00-4805-a150-4d847ad7d559 |
| PRODUCT NDC: | 51285-131 |
| APPLICATION NUMBER: | ANDA076380 |
Other NORETHINDRONE ACETATE; ETHINYL ESTRADIOL Pharmaceutical Manufacturers / Labelers:
